Our Brain Cancer Clinical Trial is investigating Sonodynamic Therapy. A painless, non-invasive ultrasonic technology for the treatment of glioblastoma.
Location: United States, Minnesota, Oakdale
Employees: 1-10
Total raised: $68M
Investors 4
| Date | Name | Website |
| - | BrightEdge | brightedge... |
| - | OrbiMed | orbimed.co... |
| 21.12.2021 | Action Pot... | actionpote... |
| - | BrightEdge | acsbrighte... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 16.05.2025 | Series B | $52M | - |
| 17.11.2021 | Series A | $16M | - |
Mentions in press and media 7
| Date | Title | Description |
| 17.05.2025 | Alpheus Medical: A New Dawn in Glioblastoma Treatment | In the world of oncology, glioblastoma stands as a formidable foe. This aggressive brain cancer is notorious for its complexity and resistance to treatment. Yet, a beacon of hope shines through the darkness. Alpheus Medical, a clinical-stag... |
| 16.05.2025 | Alpheus Medical: $52 Million Series B Raised For Glioblastoma Therapy Technology | Alpheus Medical – a clinical-stage oncology company pioneering sonodynamic therapy (SDT) for the treatment of solid body cancers – announced the closing of an oversubscribed $52 million Series B financing round. This funding round was co-le... |
| 15.05.2025 | Alpheus Medical Raises $52M in Series B Funding | Alpheus Medical, a Chanhassen, MN-based private, clinical-stage oncology company, raised $52M in Series B funding. The round was led by HealthQuest Capital and Samsara BioCapital with participation from existing investors OrbiMed, Action Po... |
| 17.11.2021 | Alpheus Medical Closes $16M In Series A Financing For Novel Glioma Brain Cancer Treatment | OAKDALE, Minn., Nov. 17, 2021 /PRNewswire/ -- Alpheus™ Medical, Inc, a privately held company developing a novel sonodynamic therapy (SDT) platform targeting solid body cancers, today announced it has closed $16M in Series A financing. Co-l... |
| - | FDA Grants Alpheus Medical Orphan Drug and Fast Track Designations for Novel Sonodynamic Therapy for Brain Cancer | See original press release here. |
| - | Alpheus Medical | “Our Brain Cancer Clinical Trial is investigating Sonodynamic Therapy. A painless, non-invasive ultrasonic technology for the treatment of glioblastoma.” |
| - | Alpheus Medical Announces Formation of World-Class Scientific Advisory Board (SAB) to Support Development of Novel Treatment for Brain Cancer | The original press release can be found here. |